Company News

Share this article:

Aventis Pharmaceutical, a subsidiary of Sanofi-Aventis, will pay $95.5 million to settle Department of Justice allegations that it violated the False Claims Act by misreporting drug prices to reduce its Medicaid Drug Rebate obligations. The allegations refer to pricing on Azmacort, Nasacort and Nasacort AQ, between 1995 and 2000.

 

WeissComm Group announced the acquisition of Common Sense Media Group, a social media consulting company founded by Bob Pearson, who will become WeissComm's chief technology and media officer. WeissComm also signed a strategic alliance with Rule 13, a firm focused on social media education, research and training.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.